UPT Perpustakaan Universitas Andalas
Repositori PerpustakaanUniversitas Andalas
 

Hubungan Derajat Aktivitas Penyakit dengan Kejadian Infeksi pada Pasien Lupus Eritematosus Sistemik di Instalasi Rawat Inap RSUP Dr. M. Djamil Padang

dc.contributor.advisorNetti, Suharti
dc.contributor.advisorDwitya, Elvira
dc.contributor.authorIsra, Alfisyahri Gunawan
dc.date.accessioned2026-09-24T17:56:38Z
dc.date.issued2026-01-12
dc.descriptionDr. dr. Netti Suharti, M.Kes; Dr. dr. Dwitya Elvira, Sp.PD-KAI, FINASIM.
dc.description.abstractInfeksi menjadi salah satu penyebab utama morbiditas dan mortalitas pada pasien LES, dengan tingkat rawat inap 12 kali lebih tinggi dibandingkan populasi umum. Kerentanan terhadap infeksi berhubungan dengan respons imun yang terganggu, diperburuk oleh tingginya aktivitas penyakit, keterlibatan organ, serta penggunaan terapi imunosupresif untuk mengendalikan aktivitas penyakit. Penelitian ini bertujuan untuk menganalisis hubungan antara derajat aktivitas penyakit dengan kejadian infeksi pada pasien LES di Instalasi Rawat Inap RSUP Dr. M. Djamil Padang. Penelitian ini merupakan studi analitik observasional dengan pendekatan cross sectional menggunakan data sekunder dari rekam medis pasien LES yang dirawat di Instalasi Rawat Inap RSUP Dr. M. Djamil Padang selama tahun 2024. Total 162 pasien LES memenuhi kriteria inklusi dan eksklusi untuk dianalisis. Data dianalisis menggunakan uji Chi-square. Hasil penelitian ini menunjukkan sebagian besar pasien LES berada pada derajat aktivitas penyakit sedang hingga berat (67.3%), dan kejadian infeksi ditemukan pada 111 pasien (68.5%). Analisis bivariat menunjukkan terdapat hubungan signifikan antara derajat aktivitas penyakit dengan kejadian infeksi (p=0.001). Proporsi infeksi lebih tinggi pada kelompok derajat aktivitas penyakit sedang-berat (77.1%) dibandingkan remisi-ringan (50.9%). Pasien dengan aktivitas penyakit sedang–berat memiliki odds infeksi 3.2 kali lebih besar dibandingkan pasien remisi-ringan (OR 3.236; 95% CI 1.607–6.513; p=0.001). Simpulan dari penelitian ini adalah terdapat hubungan antara derajat aktivitas penyakit dengan kejadian infeksi pada pasien LES di Instalasi Rawat Inap RSUP Dr. M. Djamil Padang.
dc.identifier.urihttps://ailib.my.id/handle/123456789/8572
dc.language.isoid
dc.publisherUniversitas Andalas
dc.subjectLupus Eritematosus Sistemik
dc.subjectInfeksi
dc.subjectMex-SLEDAI
dc.subjectDerajat Aktivitas Penyakit
dc.subjectRawat Inap
dc.subject.classificationR Medicine (General)
dc.titleHubungan Derajat Aktivitas Penyakit dengan Kejadian Infeksi pada Pasien Lupus Eritematosus Sistemik di Instalasi Rawat Inap RSUP Dr. M. Djamil Padang
dc.typeThesis
dcterms.dateSubmitted2026-01-20
dcterms.references1. García BEC, Pesántez MPC, Carbaca VXV, Álvarez RAV, Betancourt VJM, Barriga JPG, et al. Systemic lupus erythematosus: update οn the diagnosis, prevalence, clinical management, inflammatory markers, new horizons in the pathogenesis, manifestations and progress in treatment. EPRA International Journal of Multidisciplinary Research (IJMR). 2024;10(2):317–25. 2. Chan SCW, Lau CS. Systemic lupus erythematosus and immunodeficiency. Rheumatology and Immunology Research. 2021;2(3):131–8. 3. Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023;82(3):351–6. 4. Kementerian Kesehatan RI. Kemenkes tingkatkan upaya deteksi dini lupus melalui program saluri. Kementerian Kesehatan RI. https://kemkes.go.id/id/rilis-kesehatan/kemenkes-tingkatkan-upaya-deteksi-dini-lupus-melalui-program-saluri. – Diakses Januari 2025. 5. Kementerian Kesehatan RI. Situasi lupus di Indonesia. Pusat Data dan Informasi. Jakarta; 2017. https://kanalpengetahuan.fk.ugm.ac.id/situasi-lupus-di-indonesia/ – Diakses Januari 2025. 6. Rahayu DS, Udijono A, Saraswati LD. Hubungan tingkat pengetahuan dan tingkat kepatuhan minum obat dengan tingkat kekambuhan lupus eritematosus sistemik. Jurnal Epidemiologi Kesehatan Komunitas. 2021;6(2):261–8. 7. Resmana FR. Faktor risiko kejadian penyakit systemic lupus erythematosus (SLE) di RSUP Dr. M. Djamil Padang tahun 2017 (Skripsi). Padang: Universitas Andalas; 2018. 8. Vaillant AAJ, Goyal A, Varacallo MA. Systemic lupus erythematosus. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK535405/. – Diakses Januari 2025. 9. Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update in the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14–25. 10. Sumariyono, Kalim H, Setyohadi B, Hidayat R, Najirman, Hamijoyo L, et al. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Jakarta: Perhimpunan Reumatologi Indonesia; 2019. 11. He J, Li Z. Dilemma of immunosuppression and infection risk in systemic lupus erythematosus. Rheumatology. 2023;62:I22-9. 12. Al-Gahtani SN. A review of systemic lupus erythematosus (SLE): symptoms, risk factors, treatment, and health related quality of life issues. Open J Rheumatol Autoimmune Dis. 2021;11(04):115–43. 13. Battaglia M, Garrett-Sinha LA. Bacterial infections in lupus: roles in promoting immune activation and in pathogenesis of the disease. J Transl Autoimmun. 2021;4:100078. 14. Trilistyoati D, Agustina B, Awalia A. Clinical profile and incidence of infection in systemic lupus erythematosus patients at medical inpatient installation, department of internal medicine, dr. Soetomo general academic hospital, Surabaya, Indonesia in 2016. Majalah Biomorfologi. 2021;31(2):49–56. 15. Ramadhani D. Gambaran infeksi pada penderita sistemik lupus eritematosus di rumah sakit umum pusat haji adam malik Medan tahun 2012-2017 (Skripsi). Medan: Universitas Sumatera Utara; 2017. 16. Dhital R, Pandey RK, Poudel DR, Oladunjoye O, Paudel P, Karmacharya P. All-cause hospitalizations and mortality in systemic lupus erythematosus in the US: results from a national inpatient database. Rheumatol Int. 2020;40(3):393–7. 17. Pego-Reigosa JM, Nicholson L, Pooley N, Langham S, Embleton N, Marjenberg Z, et al. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology. 2021;60(1):60–72. 18. Singh BK, Singh S. Systemic lupus erythematosus and infections. Reumatismo. 2020;72(3):154–69. 19. Barber MRW, Clarke AE. Systemic lupus erythematosus and risk of infection. Expert Review of Clinical Imunology. 2020;16(5):527–38. 20. Sari MK, Satria CD, Arguni E. Predictors of Infection in Children with Systemic Lupus Erythematosus: A Single Center Study in Indonesia. Glob Pediatr Health. 2021;8. 21. Jung JY, Suh CH. Infection in systemic lupus erythematosus, similarities, and differences with lupus flare. Korean Journal of Internal Medicine. 2017;32(3):429–38. 22. Yuan Q, Xing X, Lu Z, Li X. Clinical characteristics and risk factors of infection in patients with systemic lupus erythematosus: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum. 2020;50(5):1022–39. 23. Uribe AG, Vilá LM, McGwin G, Sanchez ML, Reveille JD, Alarcón GS. The systemic lupus activity measure-revised, the mexican systemic lupus erythematosus disease activity index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol. 2004;31(10):1934–40. 24. Kasjmir YI, Handono K, Wijaya LK, Hamijoyo L, Albar Z, Kalim H, et al. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Perhimpunan Reumatologi Indonesia; 2011. 25. Skare TL, Dagostini JS, Zanardi PI, Nisihara RM. Infections and systemic lupus erythematosus. Einstein (Sao Paulo). 2016;14(1):47–51. 26. Dorgham DA, Anwar S, Khaled AS. Infection in systemic lupus erythematosus patients. Egyptian Rheumatologist. 2021;43(2):115–8. 27. Li G, Liu X, Zhao J. Clinical characteristics, microbiological and risk factors of infections in patients with systemic lupus erythematosus. J Community Hosp Intern Med Perspect. 2025;15(1):36–41. 28. Haikel KAB, Tulaihi B Al. Awareness of systemic lupus erythematosus among primary health care patients in Riyadh, Saudi Arabia. Saudi Med J. 2019;40(2):177–82. 29. Izmirly PM, Parton H, Wang L, McCune WJ, Lim SS, Drenkard C, et al. Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta‐Analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis & Rheumatology. 2021;73(6):991–6. 30. Ferrara P, Antonazzo IC, Zamparini M, Fornari C, Borrelli C, Boarino S, et al. Epidemiology of SLE in Italy: an observational study using a primary care database. Lupus Sci Med. 2024;11(1):1–9. 31. Ameer MA, Chaudhry H, Mushtaq J, Khan OS, Babar M, Hashim T, et al. An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus. 2022;14(10). 32. Sestan M, Kifer N, Arsov T, Cook M, Ellyard J, Vinuesa CG, et al. The role of genetic risk factors in pathogenesis of childhood-onset systemic lupus erythematosus. Curr Issues Mol Biol. 2023;45(7):5981–6002. 33. Deng Y, Tsao BP. Updates in lupus genetics. Curr Rheumatol Rep. 2017;19(68). 34. Kim JW, Kim HA, Suh CH, Jung JY. Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus. Front Med. 2022;9. 35. Tsokos GC, Lo MS, Reis PC, Sullivan KE. New Insights into the Immunopathogenesis of Systemic Lupus Erythematosus. Nat Rev Rheumatol. 2016;12(12):716–30. 36. Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N, et al. Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev. 2008;8(1):24–8. 37. Accapezzato D, Caccavale R, Paroli MP, Gioia C, Nguyen BL, Spadea L, et al. Advances in the pathogenesis and treatment of systemic lupus erythematosus [Internet]. International Journal of Molecular Sciences. 2023 [cited 2025 Feb 16]. Available from: https://www.mdpi.com/2226890. 38. Vieira AA, Almada-Correia I, Inácio J, Costa-Reis P, da Rocha ST. Female-bias in systemic lupus erythematosus: how much is the x chromosome to blame? Biol Sex Differ. 2024;15(1):76. 39. Smith CF, J. Hoover P, Kalunian K. Systemic lupus erythematosus. In: Jameson JL, Fauci AS, Kasper DL, et al. Harrison’s principles of internal medicine. 22nd ed. New York: McGraw-Hill; 2025; p. 368. 40. Yung S, Yap DY, Chan TM. A review of advances in the understanding of lupus nephritis pathogenesis as a basis for emerging therapies. F1000Res. 2020;9:905 https://f1000research.com/articles/9-905/v1. – Diakses Februari 2025. 41. Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172(11):ITC82-96. 42. Bertsias G, Cervera R, Boumpas DT. Systemic lupus erythematosus: pathogenesis and clinical features. In: EULAR Textbook on Rheumatic Diseases. 2012. p. 476–505. 43. Ribero S, Sciascia S, Borradori L, Lipsker D. The cutaneous spectrum of lupus erythematosus. Clin Rev Allergy Immunol. 2017;53(3):291–305. 44. Jordan N, D’Cruz D. Clinical review - systemic lupus erythematosus. Championing and informing general practice professionals. https://www.gponline.com/clinical-review-systemic-lupus-erythematosus/article/1087060. – Diakses Februari 2025 45. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis and Rheumatology. 2019;71(9):1400–12. 46. Abdwani R, Masroori E, Abdullah E, Al Abrawi S, Al-Zakwani I. Evaluating the performance of ACR, SLICC and EULAR/ACR classification criteria in childhood onset systemic lupus erythematosus. Pediatric Rheumatology. 2021;19(1). 47. Lee WS, Amengual O. B cells targeting therapy in the management of systemic lupus erythematosus. Immunol Med. 2020;43(1):16–35. 48. Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1–13. 49. Luijten RKMAC, Cuppen BVJ, Bijlsma JWJ, Derksen RHWM. Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections. Lupus. 2014;23(14):1512–6. 50. Hu SCS, Yen FL, Wang TN, Lin YC, Lin CL, Chen GS. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study. J Am Acad Dermatol. 2016;75(1):49–58. 51. García-Carrasco M, Mendoza-Pinto C, Rojas-Villarraga A, Molano-González N, Vallejo-Ruiz V, Munguía-Realpozo P, et al. Prevalence of cervical HPV infection in women with systemic lupus erythematosus: a systematic review and meta-analysis. Vol. 18, Autoimmunity Reviews. Elsevier B.V. 2019;18(2):184–91. 52. Tanveer S, Pan CW, Sami F, Romero Noboa ME, Cornejo Gonzalez DM, Patolia K, et al. Fungal infections in hospitalized patients of systemic lupus erythematosus: a united states nationwide cohort analysis. Cureus. 2024;16. 53. Karuniawati A. Diagnostic stewardship dalam penanganan penyakit infeksi. Journal of The Indonesian Medical Association. 2023;73(5):213–7. 54. Hou C, Jin O, Zhang X. Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus. Clin Rheumatol. 2018;37(10):2699–705. 55. Huang M, Cai S, Su J. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 2019;20(21):5376–406. 56. Wiersinga WJ, van der Poll T. Immunopathophysiology of human sepsis. EBioMedicine. 2022;86:104363–72. 57. Sciascia S, Cuadrado MJ, Karim MY. Management of infection in systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2013;27(3):377–89. 58. Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–45. 59. Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, Van Assen S, Bijl M, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79(1):39–52. 60. Ko T, Koelmeyer R, Li N, Yap K, Yeo AL, Kent J, et al. Predictors of infection requiring hospitalization in patients with systemic lupus erythematosus: a time-to-event analysis. Semin Arthritis Rheum. 2022;57: 152099. 61. Lazar S, Kahlenberg JM. Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med. 2023;74:339–52. 62. Wang X, Zuo X, Xie X, Luo H, Zhang W, Duan L, et al. Risk factors for serious infections in inpatients with systemic lupus erythematosus. J Cent South Univ (Med Sci). 2021;46(7):704–10. 63. Tjan B, Kambayana G, Kurniari PK. Gambaran profil systemic lupus erythematosus (SLE) dan lupus nefritis di rumah sakit umum pusat Sanglah. Jurnal Penyakit Dalam Udayana. 2022;6(2):31–5. 64. Suri HE. Faktor yang berhubungan dengan mortalitas pada pasien lupus eritematosus sistemik di Rumah Sakit Dr. M. Djamil Padang. (Thesis). Padang: Universitas Andalas; 2025. 65. Selvananda S, Chong YY, Thundyil RJ. Disease activity and damage in hospitalized lupus patients: a Sabah perspective. Lupus. 2020;29(3):344–50. 66. Jung JY, Yoon D, Choi Y, Kim HA, Suh CH. Associated clinical factors for serious infections in patients with systemic lupus erythematosus. Sci Rep. 2019;9(1):9704. 67. Forsyth KS, Jiwrajka N, Lovell CD, Toothacre NE, Anguera MC. The conneXion between sex and immune responses. Nat Rev Immunol. 2024;24(7):487–502. 68. Christou EAA, Banos A, Kosmara D, Bertsias GK, Boumpas DT. Sexual dimorphism in SLE: above and beyond sex hormones. Lupus. 2019;28(1):3–10. 69. Rajadhyaksha AG, Jobanputra K. Infections in systemic lupus erythematosus. Article in Journal of the Association of Physicians of India. 2020;68:18–21. 70. Çetin Ç, Can MG, Öztaşkın S, Yalçınkaya Y, Gül A, İnanç M, et al. Analysis of 5-year hospitalization data of patients with systemic lupus erythematosus: Damage is a risk factor for frequent and longer stays. Lupus. 2024;33(3):232–40. 71. Porta S, Danza A, Arias Saavedra M, Carlomagno A, Goizueta MC, Vivero F, et al. Glucocorticoids in systemic lupus erythematosus. Ten questions and some issues. J Clin Med. 2020;9(9):2709. 72. Torres-Ruiz J, Mejía-Domínguez NR, Zentella-Dehesa A, Ponce-De-León A, Morales-Padilla SR, Vázquez-Rodríguez R, et al. The systemic lupus erythematosus infection predictive index (LIPI): a clinical-immunological tool to predict infections in lupus patients. Front Immunol. 2019;10. 73. Ma J, Zhang L, Yan M, Liu Z, Xue L. Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study. Lupus Sci Med. 2024;11(1):e001196. 74. Chuah SL, Teh CL, Wan Mohd Akbar SA, Cheong YK, Sachdev Manjit Singh B. Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic. Ann Rheum Dis. 2022;81(8):e144. 75. Fernandez-Ruiz R, Paredes JL, Niewold TB. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease. Translational Research. 2021;232:13–36. 76. Manadan AM, Kambhatla S, Gauto‐Mariotti E, Okoli C, Block JA. Reasons for hospitalization and in‐hospital mortality in adult systemic lupus erythematosus. ACR Open Rheumatol. 2020;2(11):683–9. 77. Perrotta N, López Meiller MJ, Malah V, Dubinsky D. Reasons for hospitalisation in patients with systemic lupus erythematosus in a university hospital in Buenos Aires. Reumatología Clínica (English Edition). 2021;17(8):471–4. 78. Di Bartolomeo S, Alunno A, Carubbi F. Respiratory manifestations in systemic lupus erythematosus. Pharmaceuticals. 2021;14(3):276. 79. Ernstmeyer K, Christman E. Mobility. Nursing Fundamentals. 2021. https://www.ncbi.nlm.nih.gov/books/NBK591828/ – Diakses Oktober 2025. 80. Kunzler ALF, Tsokos GC. Infections in Patients with Systemic Lupus Erythematosus: The Contribution of Primary Immune Defects Versus Treatment-Induced Immunosuppression. Eur J Rheumatol. 2023;10(4):148–58. 81. Rao M, Mikdashi J. A framework to overcome challenges in the management of infections in patients with systemic lupus erythematosus. Open Access Rheumatol. 2023;15:125–37. 82. Chen D, Xie J, Chen H, Yang Y, Zhan Z, Liang L, et al. Infection in Southern Chinese patients with systemic lupus erythematosus: spectrum, drug resistance, outcomes, and risk factors. J Rheumatol. 2016;43(9):1650–6. 83. Teh CL, Wan SA, Ling GR. Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality. Clin Rheumatol. 2018;37(8):2081–6. 84. Mohamed DF, Habeeb RA, Hosny SM, Ebrahim SE. Incidence and risk of infection in Egyptian patients with systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord. 2014;7:41–8.
local.eprints.dirdisk0/00/51/73/29
local.eprints.divisionS1KEDOK2024
local.eprints.id517329
local.eprints.typethesis/2Sarjana
local.eprints.urihttp://scholar.unand.ac.id/517329/
local.fakultasFakultas Kedokteran
local.identifier.nim2110311073
local.prodiS1 Kedokteran
local.thesis.levelSkripsi

Files

Collections